Aim. To evaluate the clinical efficiency of the individually dosed interval hypoxia-hyperoxic therapy in the medical rehabilitation of patients with osteoarthritis (OA), having post-COVID syndrome. Material and methods. 50 patients with OA (84% females, age of 43 to 68 years) where included in the randomized placebo-controlled study. Coronavirus infection COVID-19 were diagnosed from 12 to 26 weeks before the study. Patients had at least 6 symptoms of post-COVID syndrome. All patients were randomized into 3 groups. 18 patients of the study group received 10 hypoxia-hyperoxic therapy procedures, 15 comparison group patients – 10 placebo procedures, 14 control group patients – only standard rehabilitation. The study group patients were breathing hypoxic (FiO2 13–15%) and hyperoxic (FiO2 up to 40%) gas mixture through the mask in the interval mode using device ReOxy. The duration of 1–4 procedures was 30 min, 5–10 procedures – 40 min. The placebo procedures were performed using the mask with the atmospheric air hole. The standard rehabilitation program in all groups for 2 weeks included: 10 group sessions of physical exercises with elements of breathing exercises, 10 procedures of magnetic therapy for joints, 10 sodium chloride baths. Joint pain and general health on 100-mm visual analog scale, Lequesne and WOMAC indexes, Spielberger-Khanin reactive anxiety test, Beck depression inventory and breathlessness on Modified Borg scale were evaluated at baseline (control point T0) and at 2 weeks (control point T1). Results and discussion. After 2 weeks (T1) in the study group, pain decreased by 51.4% (p < 0.01), Lequesne index – by 34.8% (p < 0.05), WOMAC – by 44.7% (p < 0.05), reactive anxiety level – by 23.7% (p < 0.05), depression symptoms – by 52.9% (p < 0.01), breathlessness – by 71.2% (p < 0.01), general health improved by 52.1% (p < 0.01). In the study group, there were statistically significant differences from the control group in all parameters (p < 0.05) and from the comparison group in most indicators (p < 0.05), excluding the Lequesne index. These results are consistent with the data of modern studies of efficiency of hypoxic conditioning. Conclusion. 2-week rehabilitation program, including interval hypoxia-hyperoxic therapy, reduces pain, breathlessness, depression and reactive anxiety symptoms, improves general health and functional status in patients with OA, having post-COVID syndrome.
osteoarthritis, post-COVID syndrome, rehabilitation, hypoxia-hyperoxic therapy, individually dosed intermittent hypoxia, hypoxic conditioning
1. Nasonova E.L. Rossiyskie klinicheskie rekomendacii. Revmatologiya. Moskva. GEOTAR Media. 2019: 464 s.
2. Alekseeva L.I., Taskina E.A., Kashevarova N.G. Osteoartrit: epidemiologiya, klassifikaciya, faktory riska i progressirovaniya, klinika, diagnostika, lechenie. Sovremennaya revmatologiya. 2019; 13(2): 9-21. https://doi.org/10.14412/1996-7012-2019-2-9-21
3. Naumova A.V., Alekseeva L.I. Vedenie bol'nyh s osteoartritom i komorbidnost'yu v obschey vrachebnoy praktike. Klinicheskie rekomen- dacii. Moskva. 2016: 40 c.
4. Vorob'eva P.A. Rekomendacii po vedeniyu bol'nyh s koronavirusnoy infekciey COVID-19 v ostroy faze i pri postkovidnom sindrome v ambulatornyh usloviyah. Problemy standartizacii v zdravoohranenii. 2021; (7-8): 3-96. https://doi.org/10.26347/1607-2502202107-08003-096
5. Dennis A., Wamil M., Kapur S., Alberts J., Badley A.D., Decker G.A., Rizza S.A., Banerjee R., Banerjee A. Multi-organ impairment in low-risk individuals with long COVID. MedRxiv. 2020. https://doi.org/10.1101/2020.10.14.20212555
6. Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re’em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021; 38(2001): 101019 p. https://doi.org/10.1016/j.eclinm.2021.101019
7. Pugh C.W., Ratcliffe P.J. New horizons in hypoxia signaling pathways. Experimental Cell Research. 2017; 356(2): 116-121. https://doi.org/10.1016/j.yexcr.2017.03.008
8. Glazachev O.S., Lyamina N.P., Spirina G.K. Interval'noe gipoksicheskoe kondicionirovanie: opyt i perspektivy primeneniya v programmah kardioreabilitacii. Rossiyskiy kardiologicheskiy zhurnal. 2021; 26(5): 156-162. https://doi.org/10.15829/1560-4071-2021-4426
9. Serebrovska T.V., Portnychenko A.G., Drevytska T.I., Portnichenko V.I., Xi L., Egorov E., Gavalko A.V, Naskalova S., Chizhova V., Shatylo V.B. Intermittent hypoxia training in prediabetes patients: Beneficial effects on glucose homeostasis, hypoxia tolerance and gene expression. Experimental Biology and Medicine. 2017; 242(15): 1542-1552. https://doi.org/10.1177/1535370217723578
10. Chacaroun S., Borowik A., Morrison S.A., Baillieul S., Flore P., Doutreleau S., Verges S. Physiological Responses to Two Hypoxic Conditioning Strategies in Healthy Subjects. Frontiers in Physiology. 2016; (7): 675 p. https://doi.org/10.3389/fphys.2016.00675
11. Tobin B., Costalat G., Renshaw G.M.C. Intermittent not continuous hypoxia provoked haematological adaptations in healthy seniors: hypoxic pattern may hold the key. European Journal of Applied Physiology. 2020; 120(3): 707-718. https://doi.org/10.1007/s00421-020-04310-y
12. Kryzhanovskaya S.Yu., Dudnik E.N., Zapara M.A., Samarceva V.G., Glazachev O.S. Procedury gipoksicheskogo kondicionirovaniya ne privodyat k chrezmernoy aktivacii oksidativnogo stressa u prakticheski zdorovyh obsleduemyh. Rossiyskiy fiziologicheskiy zhurnal im. I.M. Seche- nova. 2019; 105(1): 89-99. https://doi.org/10.1134/S0869813919010047
13. Serebrovska Z.O, Chong E.Y., Serebrovska T.V., Tumanovska L.V., Xi L. Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets. Acta Pharmacologica Sinica. 2020; 41(12): 1539-1546. https://doi.org/10.1038/s41401-020-00554-8
14. Timon R., Martínez-Guardado I., Camacho-Cardeñosa A., Villa-Andrada J.M., Olcina G., Camacho-Cardeñosa M. Effect of intermittent hypoxic conditioning on inflammatory biomarkers in older adults. Experimental Gerontology. 2021; (152): 111478 p. https://doi.org/10.1016/j.exger.2021.111478
15. Nasonov E.L. Immunopatologiya i immunofarmakoterapiya koronavirusnoy bolezni 2019 (COVID-19): fokus na interleykin 6. Nauchno-prak- ticheskaya revmatologiya. 2020; 58(3): 245-261.
16. Bestavashvili A.A., Glazachev O.S., Bestavashvili A.A., Dhif I., Suvorov A.Yu., Vorontsov N.V., Tuter D.S., Gognieva D.G., Yong Z., Pavlov Ch.S., Glushenkov D.V., Sirkina E.A., Kaloshina I.V., Kopylov P.Yu. The Effects of Intermittent Hypoxic-Hyperoxic Exposures on Lipid Profile and Inflammation in Patients with Metabolic Syndrome. Frontiers in Cardiovascular Medicine. 2021; (8): 700826 p. https://doi.org/10.3389/fcvm.2021.700826
17. Serebrovska Z.O., Serebrovska T.V., Kholin V.A., Tumanovska L.V., Shysh A.M., Pashevin D.A., Goncharov S.V., Stroy D., Grib O.N., Shatylo V.B., Bachinskaya N.Yu., Egorov E., Xi L., Dosenko Victor E. Intermittent Hypoxia-Hyperoxia Training Improves Cognitive Function and Decreases Circulating Biomarkers of Alzheimer’s Disease in Patients with Mild Cognitive Impairment: A Pilot Study. International Journal of Molecular Sciences. 2019; 20(21): 5405 p. https://doi.org/10.3390/ijms20215405
18. Timon R., Camacho-Cardeñosa M., González-Custodio A., Olcina G., Gusi N., Camacho-Cardeñosa A. Effect of hypoxic conditioning on functional fitness, balance and fear of falling in healthy older adults: a randomized controlled trial. European Review of Aging and Physical Activity. 2021; 18(1): 25 p. https://doi.org/10.1186/s11556-021-00279-5
